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ABSTRACT – Background – Neonatal cholestasis syndrome with an intra or extrahepatic origin has been associated to viral
infections. The participation of the cytomegalovirus in the etiopathogenesis of neonatal hepatitis has been already known for
some time, but only recently there have been indications that this virus may be one of the possible etiological factors for
extrahepatic biliary atresia. Aims - To assess the prevalence of infection by cytomegalovirus in patients with intrahepatic
cholestasis and extrahepatic cholestasis. To compare the clinical characteristics of the intrahepatic cholestasis and extrahepatic
cholestasis groups with the cytomegalovirus serological results. Patients and Methods - This study consisted of 76 patients with
neonatal cholestasis who were admitted between January 1980 and January 1999 when they underwent a cytomegalovirus
serologic study using the ELISA method. A case note was kept on each patient with the following data: age of patient at
admission, serologic result for cytomegalovirus, history of maternal infection, prematurity, fetal distress, birth weight, ponderal
gain, choluria and fecal acholia. The final anatomic diagnosis of cholestasis was based on the results of an abdominal
ultrasonography, a liver biopsy and its evolution. The patients were then divided into two groups: group I - intrahepatic
cholestasis and group II – extrahepatic cholestasis. Each of these groups were then divided into two subgroups: subgroup A -
positive serology (IgM) for cytomegalovirus and subgroup B – negative serology (IgM) for cytomegalovirus. Results - The
frequency of positive serology (IgM) for cytomegalovirus was 29.4% in children with intrahepatic cholestasis and 28.5% in
children with extrahepatic cholestasis. In comparison with group IIB, group IIA presented a higher rate of maternal infection
history. The patients in group IIA demonstrated a delayed access to the service in comparison with group IA. The groups did
not demonstrate any significant differences regarding the onset age of jaundice, choluria and fecal acholia, birth weight and
ponderal gain. Conclusions - The positive (IgM) seroprevalence for cytomegalovirus in children with intrahepatic cholestasis
and extrahepatic cholestasis is high. The history of maternal infection was more common in extrahepatic cholestasis patients
with positive serology for cytomegalovirus. There was a delay in the referral of these patients which resulted in a late diagnosis
and surgical treatment.
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INTRODUCTION
The occurrence of neonatal cholestasis has been associated
to congenital or acquired viral infections. Previous studies
based on serologic tests indicated that the herpes group virus,
especially cytomegalovirus (CMV) was implicated in the
development of intrahepatic neonatal cholestasis(16).
Infections due to CMV are present in about 1% to 2.4%
of newborns in North America and in our country(5, 22, 26), but
at the end of the first year of life, this very same infection is
present in up to 60% of the children in the west(11, 12).
Intrauterine CMV transmission is due to primary or
recurring maternal infections and it causes the greatest
damages to the fetus when it occurs in the early pregnancy
stages(6). However, the risk of fetal transmission seems greater
when the maternal infection occurs during the final pregnancy
trimester(15, 18, 20). The fetal infection may cause: the
interruption of the pregnancy, prematurity, low birth weight
in full term newborns and several congenital malformations
such as inguinal hernia, cleft palate, dental abnormalities,
polycystic kidneys, mitral and pulmonary stenosis, atrial and
ventricular septal defects and atresia of the biliary ducts(7, 21).
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The clinical symptoms of cytomegalovirus in full term neonates varies
from an asymptomatic condition to a fully disseminated terminal
condition. When the disease is clearly manifested in neonates they
frequently show: jaundice, hemorrhagic suffusion, hepatos-
plenomegaly, microcephaly, chorioretinitis, deafness, and
neuromuscular dysfunctions. The main laboratory findings are:
anemia, thrombocytopenia, and periventricular calcification of the
central nervous system(14).
On the other hand, a perinatal infection occurs more frequently
than a congenital infection, and the main source of infection is the
maternal contact, either through cervical secretion during delivery
or later through breast feeding, as the virus was found in both
secretions obtained from seropositive CMV asymptomatic pregnant
women(9, 10, 18). A CMV perinatal infection usually presents an
asymptomatic clinical development which appears as a cholestatic
syndrome(2, 23) .
Neonatal cholestatic syndrome may be a result of an intrahepatic
or extrahepatic alterations. The etiologies of the intrahepatic group
are included in one of the following subgroups: metabolic, toxic-
medication, hereditary, anatomic and idiopathic infections. The main
etiologies of the extrahepatic group are atresia of the extrahepatic
biliary atresia (EHBA) and choledochal cysts.
EHBA is the final result of a destructive inflammatory process
that affects the intrahepatic and extrahepatic biliary ducts leading to
fibrosis and obliteration of the biliary tract at some point between the
porta hepatis and the duodenum. The etiology of the disease is
unknown, although there is a definite attractiveness in a hypothesis
incriminating an in utero viral insult to the hepatobiliary system. The
viruses studied in children with EHBA were reovirus type 3, rotavirus
and CMV, but the results in relation to viral participation were
controversial and inconclusive(1).
Therefore, this study had the following aims: 1) to evaluate the
prevalence of infection due to CMV in patients with intrahepatic
cholestasis (IHC) and extrahepatic cholestasis (EHC); 2) to compare
the clinical characteristics of the IHC and EHC groups with positive
and negative serology for CMV .
CASUISTIC AND METHODS
A retrospective study was conducted in 147 patients who
were admitted with neonatal cholestasis to the Pediatric
Gastroenterology Unit, University Hospital, Faculty of Medical
Sciences, State University of Campinas (HC-UNICAMP),
Campinas, SP, Brazil, between January 1980 and January 1999. A
case note was kept on each of these patients with the following
data: age of patient at admission; serologic result for CMV, IgG,
and IgM; history of maternal infection; prematurity; fetal distress;
birth weight; ponderal gain; jaundice; choluria and fecal acholia.
The age at onset was also noted for the last three items whenever
they were present. After reporting all these items, 71 patients
were excluded because they did not present serology for CVM (n
= 28) or the serological study did not differentiate between IgG
and IgM (n = 40) or even the results for IgM were doubtful during
the first examination (n = 3). At end there were 76 patients included
in the study and they underwent serology for CVM using the
ELISA method.
The final anatomic diagnosis of cholestasis was based on the
results of an abdominal ultrasonography, a liver biopsy and the
evolution. The patients were then divided into two groups: group I -
IHC and group II – EHC. Each of these groups were then divided into
two subgroups: subgroup A - positive serology (IgM) for CMV and
subgroup B – negative serology (IgM) for CMV.
Statistical analysis
Double entry tables were used to calculate the prevalence as well
as to compare the categorical variables of the groups. The relationship
between the variables was found out using the Chi-square test and
the Exact Fisher test whenever necessary. The non-parametric
Kruskal-Wallis test was used to compare the continuing variables.
The level of significance adopted was P = 0.05(19).
RESULTS
Table 1 presents the number of IHC and EHC patients with a
positive serology for CMV.
In the IHC group there were 29.4% with positive serology for
CMV and in the EHC group, 28.5% with positive serology for CMV.
This meant that there was no statistical significant difference.
Table 2 presents crossing of data: categorical variables, type of
cholestasis and serological result for CMV.
The only variable that presented a statistical difference was the
history of maternal infections.
Table 3 presents crossing of data: continuing variables, type of
cholestasis and results of serology for CMV.
The only variable that demonstrated a significant statistical
difference was the age (days) at the first consultation.
DISCUSSION
The results of this study indicated a high prevalence of CMV in
children with both intrahepatic and extrahepatic neonatal cholestasis.
It has been already known for sometime that this virus is a participant
in the etiopathogenesis of neonatal hepatitis(16, 17), but only recently it
has been indicated as a possible etiologic factor in EHBA(4, 24).
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TABLE 1 – Results of serology (IgM positive) for cytomegalovirus in group I (IHC) and in group II (EHC)
Group CMV negative CMV positive Total
I 24 10 34
II 30 12 42
Total 54 22 76
TABLE 2 – Results in percentage of some of the categorical variables studied in children with neonatal cholestasis.
Group IA = IHC and positive serology for CMV; group IB = IHC and negative serology for CMV; group
IIA = EHC and positive serology for CMV and group IIB = EHC and negative serology for CMV. The
value of P is for the following comparisons: IA x IIA; IB x IIB; IA x IB and  IIA x IIB
Items studied Group IA Group IB Group IIA Group IIB Value of P
Choluria 80,00 86,96 83,33 92,86 >0,05
Fecal Acholia 70,00 82,61 100,00 90,00 >0,05




Full term birth 50,00 59,09 91,67 78,57 >0,05
Fetal distress 33,33 14,29 0,00 8,33 >0,05
TABLE 3 – The results of the mean and median (showed between parenthesis) of some of the continuing variables
studied in children with neonatal cholestasis. Group IA = IHC and positive serology for CMV; group IB
= IHC and negative serology for CMV; group IIA = EHC and positive serology for CMV and group IIB
= EHC and negative serology for CMV. The value of P is for the following comparisons: IA x IIA; IB x IIB;
IA x IB e IIA x IIB
Items studied Group IA Group IB Group IIA Group IIB Value of P
Age (days) at the 1st 63,60 66,56 109,16 91,16 IA x IIA<
consultation (58,00) (54,00) (109,00) (77,00)  0,05
Others> 0,05
Age at onset of 19,20 20,43 3,16 12,07 >0,05
jaundice (days) (7,00) (7,00) (1,00) (3,00)
Age at onset of 35,25 16,09 36,00 11,04 >0,05
choluria (days) (31,00) (2,00) (15,00) (5,00)
Age at onset of 36,57 29,00 37,20 14,86 >0,05
acholia (days) (36,00) (30,00) (26,00) (6,50)
Birth weight 2884,00 2938,00 3228,00 3171,50 >0,05
(gm) (3160,00) (2932,50) (3140,00) (3065,00)
Ponderal gain 20,17 19,69 17,95 14,52 >0,05
(gm/day) (22,37) (20,96) (19,10) (12,69)
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CHANG et al.(3), used the polymerase chain reaction (PCR) to
study CMV in liver tissue of children with neonatal cholestasis and it
was found that out of 50 children with IHC, 23 children were positive
and in 26 children with EHBA, only 2 were positive. JEVON and
DIMMICK(8), had similar results. They did not find any patient with
CMV among the 12 children with EHBA who were studied using
PCR in the liver tissue.
FISCHLER et al.(4), on the other hand, studied 59 children with
neonatal cholestasis and found that 32% presented IgM-CMV, while
6% of the children in the control group (without cholestasis) were
positive. This positive percentage included, both, children with IHC
(11 out of 38) as well as children with EHBA (8 out of 21). When
these authors used the PCR to study this virus in the liver tissue, the
number of children found to be positive was much higher: 50%
prevalence (9 out of 18) in children with EHBA; 42.8% (3 out of 7) in
children with other types of cholestasis. These diverging results may
be due to the difference in the prevalence of this virus in the general
population or a difference in the CMV infecting strain.
The detection of a specific IgM-CMV after the 4th week of life
may be a consequence of a congenital or perinatal infection. Previous
studies made in Brazil had shown that a positive prevalence of IgM
to CMV between the 2nd and the 4th month of life varies from 8.1% to
14.7%. Therefore, when it is putting along with the detection method
of CMV at the urine by viral isolation in cultured cells, this prevalence
of the infection increases about from 30.9% to 38%, being
asymptomatic in the great majority of cases (13, 25). Based on these
results, it would be interesting the inclusion of a control group of
children without neonatal cholestasis, with an equivalent age group,
although it was not possible due to the fact that is a retrospective
study. So, the presence of a specific IgM to CMV only suggests that
this virus may be the etiologic agent of the neonatal cholestasis
syndrome but it does not confirm it.
An analysis of some of the categorical variables showed that
regarding the history of maternal infection variable, there was a
significant difference between the subgroups IIA and IIB. In these
subgroups, the serology was also negative for other infectious agents
routinely studied: syphilis, toxoplasmosis, rubella and hepatitis B. It
is likely that a significant percentage of mothers with IgM-CMV
children with EHBA presented a reactivation of the disease during
pregnancy. This hypothesis is based on the study conducted by
FISCHLER et al.(4), who observed a greater proportion of seropositive
mothers (IgG for CVM) in the group of children with neonatal
cholestasis than in the control group, and in the same way, a greater
percentage of these mothers demonstrated an increased IgG for CMV.
After analyzing some continuing variables, no difference was
observed between the subgroups regarding onset age for jaundice,
choluria, and fecal acholia. Similarly, no difference was observed
between the subgroups regarding birth weight and ponderal gain. On
the other hand, a difference was observed between the subgroups IA
and IIA regarding the age at the first consultation at the Pediatric
Gastroenterology Unit, HC-UNICAMP, which meant a delayed
referral for the subgroup with EHBA and positive serology for CVM.
The following report found at the case notes of the subgroup IIA
patients is common: mother brought the child to the doctor complaining
of jaundice and several investigations were requested by the physician.
The results confirmed that the hepatitis was viral and therefore it was
needed a period of resting. The jaundice worsened and the child was
referred to the Pediatric Gastroenterological Unit, HC-UNICAMP
where the final anatomic diagnosis was EHBA. The treatment
recommended for this disease is surgical and should be performed as
early as possible and the ideal timing is before the age of 2 months. As
seen in this study, the mean and median age at which the child was
brought to this service was approximately 31/2 months and in most
cases the delay for referral was definitely because the results showed
a positive serology (IgM) for cytomegalovirus. Hence, in many cases
the patient missed the opportunity of undergoing a surgery to restore
the biliary flow or when the surgery was performed, the results were
usually unsatisfactory.
In conclusion, in children with IHC and EHC, the positive (IgM)
seroprevalence for CVM was high. The virus in the liver tissue is
being investigated using PCR in our laboratory to find out the actual
prevalence and etiopathogenic participation of this virus in neonatal
cholestasis. The presence of positive IgM serology for CVM must
not interrupt the procedures used to differentiate IHC from EHC.
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Oliveira NLG, Kanawaty FR, Costa SCB, Hessel G.  Infecção por cytomegalovirus em pacientes com colestase neonatal.  Arq Gastroenterol
2002;39(2):132-136.
RESUMO – Racional – A síndrome colestática neonatal, de origem intra ou extra-hepática, tem sido associada à presença de infecções virais. A
participação do cytomegalovirus na etiopatogênese da hepatite neonatal já é conhecida há algum tempo e só recentemente esse vírus tem sido
implicado como dos possíveis fatores etiológicos da atresia de vias biliares extra-hepática. Objetivos - Calcular a prevalência da infecção pelo
cytomegalovirus em pacientes com colestase intra-hepática e colestase extra-hepática e comparar algumas características clínicas entre os
grupos de colestase intra-hepática e colestase extra-hepática com o resultado de sorologia para cytomegalovirus. Casuística e Métodos -
Participaram do estudo 76 pacientes com colestase neonatal admitidos durante o período de janeiro de 1980 a janeiro de 1999 que realizaram
pesquisa sorológica para cytomegalovirus pelo método ELISA. Para todos esses pacientes foi elaborada uma ficha contendo os seguintes dados:
idade do paciente na admissão, resultado de sorologia para cytomegalovirus, história de infecção materna, prematuridade, sofrimento fetal, peso
de nascimento, ganho ponderal, colúria e acolia fecal. O diagnóstico anatômico final da colestase fundamentou-se no resultado de ultra-
sonografia abdominal, biopsia hepática e evolução. Dessa forma, os pacientes foram divididos em dois grupos: I - colestase intra-hepática e II
- colestase extra-hepática. Cada um desses grupos foi dividido em dois subgrupos: A - com sorologia positiva (IgM) para cytomegalovirus e B -
com sorologia negativa (IgM) para cytomegalovirus. Resultados - A freqüência observada de sorologia positiva (IgM) para cytomegalovirus nas
crianças com colestase intra-hepática e colestase extra-hepática foi de 29,4% e 28,5%, respectivamente. O grupo IIA apresentou percentual
maior de história de infecção materna quando comparado ao grupo IIB. Os pacientes do grupo IIA apresentaram acesso mais tardio ao Serviço
em relação àqueles do grupo IA. Não foram observadas diferenças significativas entre os grupos em relação à idade de início da icterícia, colúria
e acolia fecal, bem como em relação ao peso de nascimento e ganho ponderal. Conclusões - A prevalência de sorologia positiva (IgM) para
cytomegalovirus em crianças com colestase intra-hepática e colestase extra-hepática é alta. A história de infecção materna é mais comum nos
pacientes com colestase extra-hepática e sorologia positiva para cytomegalovirus. Nesses pacientes, o encaminhamento foi mais tardio com
atraso no diagnóstico e no tratamento cirúrgico.
DESCRITORES – Infecções por cytomegalovirus. Obstrução das vias biliares extra-hepáticas. Colestasia intra-hepática.
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